Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Sayer

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|November 17, 2019
Post-transplant diabetesSamuel Duffy, John Sayer
Biochemical and Biophysical Research Communications|October 3, 2003
A role for CBS domain 2 in trafficking of chloride channel CLC-5Georgina Carr, Nicholas Simmons, John Sayer
F1000Research|November 24, 2015
Murine Cep290 phenotypes are modified by genetic backgrounds and provide an impetus for investigating disease modifier allelesSimon Ramsbottom, Colin Miles, John Sayer
Current Opinion in Urology|March 14, 2026
Genetic testing and personalized treatment for kidney stone formersRobert Geraghty, Sarah Howles, John Sayer
BMJ Case Reports|August 16, 2022
Primary biliary cholangitis presenting with Fanconi syndrome: an important phenotypeChaoxui Er, Jessica Dyson, David Jones, et al.
Nature Reviews. Nephrology|May 7, 2021
Clinical versus research genomics in kidney diseaseAndrew J Mallett, Nine Knoers, John Sayer, et al.
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
Primary hyperparathyroidism: just how 'primary' is it really?Richard Quinton, Stephen G Ball, John Sayer, et al.
Archives of Disease in Childhood. Education and Practice Edition|February 16, 2025
How to use mTOR inhibitors in childrenYincent Tse, Nicola Vasey, Rhys Thomas, et al.
Human Molecular Genetics|December 10, 2002
Expression analyses and interaction with the anaphase promoting complex protein Apc2 suggest a role for inversin in primary cilia and involvement in the cell cycleDavid Morgan, Lorraine Eley, John Sayer, et al.
BMC Nephrology|May 2, 2019
Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)Jan Dudley, Paul Winyard, Matko Marlais, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|November 17, 2019
Post-transplant diabetesSamuel Duffy, John Sayer
Biochemical and Biophysical Research Communications|October 3, 2003
A role for CBS domain 2 in trafficking of chloride channel CLC-5Georgina Carr, Nicholas Simmons, John Sayer
F1000Research|November 24, 2015
Murine Cep290 phenotypes are modified by genetic backgrounds and provide an impetus for investigating disease modifier allelesSimon Ramsbottom, Colin Miles, John Sayer
Current Opinion in Urology|March 14, 2026
Genetic testing and personalized treatment for kidney stone formersRobert Geraghty, Sarah Howles, John Sayer
BMJ Case Reports|August 16, 2022
Primary biliary cholangitis presenting with Fanconi syndrome: an important phenotypeChaoxui Er, Jessica Dyson, David Jones, et al.
Nature Reviews. Nephrology|May 7, 2021
Clinical versus research genomics in kidney diseaseAndrew J Mallett, Nine Knoers, John Sayer, et al.
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
Primary hyperparathyroidism: just how 'primary' is it really?Richard Quinton, Stephen G Ball, John Sayer, et al.
Archives of Disease in Childhood. Education and Practice Edition|February 16, 2025
How to use mTOR inhibitors in childrenYincent Tse, Nicola Vasey, Rhys Thomas, et al.
Human Molecular Genetics|December 10, 2002
Expression analyses and interaction with the anaphase promoting complex protein Apc2 suggest a role for inversin in primary cilia and involvement in the cell cycleDavid Morgan, Lorraine Eley, John Sayer, et al.
BMC Nephrology|May 2, 2019
Clinical practice guideline monitoring children and young people with, or at risk of developing autosomal dominant polycystic kidney disease (ADPKD)Jan Dudley, Paul Winyard, Matko Marlais, et al.
Pageof 2